Bioelectronic systems · Built in Germany
IEUM Bionics is building a new generation of durable, interpretable biosensing systems—beginning with Product X.
Why IEUM
Biology changes over time. IEUM designs governed systems that connect living interfaces, signal interpretation and evidence into one coherent development path.
The name IEUM means “connection” in Korean. It expresses our purpose: bringing biology and engineering together in ways that can become durable, understandable and useful.
Design begins with the dynamic environment surrounding every signal.
Systems thinking connects sensing, interpretation and engineering decisions.
Each development step is structured to build confidence through examinable evidence.
Product X
Product X turns a demanding biosensing challenge into a governed development program. Continuous glucose measurement is the first planned application.
Its current maturity is approximately TRL 2, supported by a structured system definition and evidence architecture.
View Product X readinessA governed development path
IEUM uses systems engineering to connect technical decisions with the evidence needed to advance them responsibly and efficiently.
Frame the purpose, system and evidence needs.
Activate focused technical and organizational work.
Generate evidence through qualified independent review.
Translate learning into the next value-building stage.
Platform horizon
Product X is the lead program within a broader platform and application pipeline shaped by the same connecting logic.
Founder
Junho Jung
Founder & CTO · System Architect · Solution Architect
Junho is an electrical and biomedical engineer with approximately 20 years of engineering experience across electronics, hardware development, systems engineering and medical-device technology, complemented by a neuroscience and brain–computer interface research background.
His work brings multidisciplinary ideas into governed systems whose progress can be examined through evidence.
For investors & strategic partners
IEUM has already built a double-digit portfolio of documented invention candidates and substantial groundwork for priority candidates. Financing activates staged IP protection, independent technical validation and focused company building in Germany.
